Miriam Beusink
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Miriam Beusink has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aaike van Oord
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication - Annegien Broeks
Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands
1 shared publication Casper de Boer
Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
1 shared publicationDirk-Jan Saaltink
Brain Foundation Netherlands, The Hague, the Netherlands
1 shared publicationEls van der Rhee
Brain Foundation Netherlands, The Hague, the Netherlands
1 shared publicationHanneke F. M. Rhodius-Meester
Alzheimer Center Amsterdam, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 27 January 2026
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 12 (1)
Evaluation and lessons learned regarding Public Involvement: a panel advising on an Alzheimer’s disease and related dementia cohort study
Public involvement (PI) in research is increasingly requested, yet systematic evaluation is limited. This study evaluates whether a panel advising an Alzhe
- 27 January 2026
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 12 (1)
Open AccessEvaluation and lessons learned regarding Public Involvement: a panel advising on an Alzheimer’s disease and related dementia cohort study
Public involvement (PI) in research is increasingly requested, yet systematic evaluation is limited. This study evaluates whether a panel advising an Alzhe
- Open Access
- 9 January 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Implementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients’ perspectives
Patients are generally willing to contribute to research with routinely collected health data and residual biosamples, but transparency and being able to (
- 9 January 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Open AccessImplementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients’ perspectives
Patients are generally willing to contribute to research with routinely collected health data and residual biosamples, but transparency and being able to (